Reply
Mingjiang Xu, Dechun Feng, Bin Gao – 5 June 2015
Mingjiang Xu, Dechun Feng, Bin Gao – 5 June 2015
Weijie Guo, Zhaoping Qiu, Zhichao Wang, Qifeng Wang, Ning Tan, Taoyang Chen, Zhiao Chen, Shenglin Huang, Jianren Gu, Jinjun Li, Ming Yao, Yingjun Zhao, Xianghuo He – 5 June 2015 – Cancer cells possess a unique metabolic phenotype that allows them to preferentially utilize glucose through aerobic glycolysis. This phenomenon is referred to as the “Warburg effect.” Accumulating evidence suggests that microRNAs (miRNAs), a class of small noncoding regulatory RNAs, interact with oncogenes/tumor suppressors and induce such metabolic reprograming in cancer cells.
Anastasia Asimakopoulou, Erawan Borkham‐Kamphorst, Frank Tacke, Ralf Weiskirchen – 5 June 2015
James H. Tabibian, Barham K. Abu Dayyeh, Gregory J. Gores, Michael J. Levy – 4 June 2015
Quirino Lai, Jan Lerut, For the European Hepatocellular Cancer Liver Transplant (EurHeCaLT) Study Group – 4 June 2015
James H. Tabibian, Steven P. O'Hara, Christy E. Trussoni, Pamela S. Tietz, Patrick L. Splinter, Taofic Mounajjed, Lee R. Hagey, Nicholas F. LaRusso – 4 June 2015 – Primary sclerosing cholangitis (PSC) is a chronic, idiopathic, fibroinflammatory cholangiopathy. The role of the microbiota in PSC etiopathogenesis may be fundamentally important, yet remains obscure. We tested the hypothesis that germ‐free (GF) mutltidrug resistance 2 knockout (mdr2−/−) mice develop a distinct PSC phenotype, compared to conventionally housed (CV) mdr2−/− mice.
Laura C. Burlage, Shanice A. Karangwa, Ton Lisman, Paulo N. A. Martins, Robert J. Porte – 4 June 2015
Ka‐Kit Li, Palak J. Trivedi, Sophie Von Heimendahl, Tony Bruns, Steve T. Ward, Ye Oo, David Mutimer – 4 June 2015
Marco Pavanello, Mariasavina Severino, Lorenzo D'Antiga, Lucio Castellan, Angela Calvi, Michele Colledan, Carlo Gandolfo – 4 June 2015